Literature DB >> 29957892

Liquid-based oral brush cytology in the diagnosis of oral leukoplakia using a modified Bethesda Cytology system.

Abdulhameed Alsarraf1, Omar Kujan1, Camile S Farah1,2.   

Abstract

OBJECTIVES: This study aimed to develop diagnostic criteria to identify oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs) using oral liquid-based brush cytology (OLBC), and to compare its accuracy with the gold standard of surgical biopsy and histopathological diagnosis of oral leukoplakia.
METHODS: A total number of 134 samples were collected. All patients underwent Orcellex® brush biopsy with liquid-based cytology immediately prior to diagnostic surgical biopsy. A preliminary study was first performed utilizing samples from 4 distinct lesion groups (20 samples) to revise the 2014 Bethesda Cytology system for use with OLBC specimens.
RESULTS: Five diagnostic groups of OLBC for the diagnosis of OSCC and OPMDs with relevant cytopathological features were established. From the 114 samples in the test group, 101 were included. The other 13 were excluded due to inadequate cellularity. The test showed sensitivity, specificity, positive predictive value and negative predictive value of 75%, 76%, 76% and 75%, respectively, and an accuracy of 75%. The use of the oral brush sampling technique was well accepted by multiple clinicians; however, local anaesthetic was suggested to be useful prior to performing the brush biopsy.
CONCLUSIONS: Oral liquid-based brush cytology using the Orcellex® brush and ThinPrep® system is a simple and minimally invasive procedure for adequate intraepithelial sampling and can be used as an adjunct for the early detection of oral cancer. The modified Bethesda system established useful means for OLBC assessment that can be utilized in future studies to increase the standardization of oral cytology assessment.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brush biopsy; diagnosis; liquid-based cytology; oral; oral leukoplakia

Mesh:

Year:  2018        PMID: 29957892     DOI: 10.1111/jop.12759

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Feasibility of a Video-Mosaicking Approach to Extend the Field-of-View For Reflectance Confocal Microscopy in the Oral Cavity In Vivo.

Authors:  Gary Peterson; Daniella Karassawa Zanoni; Marco Ardigo; Jocelyn C Migliacci; Snehal G Patel; Milind Rajadhyaksha
Journal:  Lasers Surg Med       Date:  2019-05-08       Impact factor: 4.025

2.  Comparison between two cell collecting methods for liquid-based brush biopsies: a consecutive and retrospective study.

Authors:  Kristin Gaida; Lena Deuerling; Heinrich Neumann; Torsten W Remmerbach
Journal:  BMC Oral Health       Date:  2021-04-16       Impact factor: 2.757

Review 3.  A Systematic Review of Oral Biopsies, Sample Types, and Detection Techniques Applied in Relation to Oral Cancer Detection.

Authors:  Guanghuan Yang; Luqi Wei; Benjamin K S Thong; Yuanyuan Fu; Io Hong Cheong; Zisis Kozlakidis; Xue Li; Hui Wang; Xiaoguang Li
Journal:  BioTech (Basel)       Date:  2022-03-02

4.  Oral brush biopsy using liquid-based cytology is a reliable tool for oral cancer screening: A cost-utility analysis: Oral brush biopsy for oral cancer screening.

Authors:  Majdy Idrees; Camile S Farah; Philip Sloan; Omar Kujan
Journal:  Cancer Cytopathol       Date:  2022-06-15       Impact factor: 4.264

5.  Immunoexpression of oral brush biopsy enhances the accuracy of diagnosis for oral lichen planus and lichenoid lesions.

Authors:  Majdy Idrees; Kate Shearston; Camile S Farah; Omar Kujan
Journal:  J Oral Pathol Med       Date:  2022-05-11       Impact factor: 3.539

6.  Clinical study on primary screening of oral cancer and precancerous lesions by oral cytology.

Authors:  Shintaro Sukegawa; Sawako Ono; Keisuke Nakano; Kiyofumi Takabatake; Hotaka Kawai; Hitoshi Nagatsuka; Yoshihiko Furuki
Journal:  Diagn Pathol       Date:  2020-09-10       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.